BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19258540)

  • 21. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
    Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
    JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
    Samadder NJ; Kuwada SK; Boucher KM; Byrne K; Kanth P; Samowitz W; Jones D; Tavtigian SV; Westover M; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Burt RW; Neklason DW
    JAMA Oncol; 2018 May; 4(5):671-677. PubMed ID: 29423501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis.
    Lynch PM; Burke CA; Phillips R; Morris JS; Slack R; Wang X; Liu J; Patterson S; Sinicrope FA; Rodriguez-Bigas MA; Half E; Bulow S; Latchford A; Clark S; Ross WA; Malone B; Hasson H; Richmond E; Hawk E
    Gut; 2016 Feb; 65(2):286-95. PubMed ID: 25792707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colon cancer: preventive agents and the present status of chemoprevention.
    Half E; Arber N
    Expert Opin Pharmacother; 2009 Feb; 10(2):211-9. PubMed ID: 19236194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.
    Bailey HH; Kim K; Verma AK; Sielaff K; Larson PO; Snow S; Lenaghan T; Viner JL; Douglas J; Dreckschmidt NE; Hamielec M; Pomplun M; Sharata HH; Puchalsky D; Berg ER; Havighurst TC; Carbone PP
    Cancer Prev Res (Phila); 2010 Jan; 3(1):35-47. PubMed ID: 20051371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of colorectal cancer: two steps forward, one step back?
    Half EE; Arber N
    Future Oncol; 2006 Dec; 2(6):697-704. PubMed ID: 17155896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-steroidal anti-inflammatory agents and prevention of colorectal adenomas and carcinomas].
    Raskov HH
    Ugeskr Laeger; 2006 Jan; 168(4):359-62. PubMed ID: 16436235
    [No Abstract]   [Full Text] [Related]  

  • 29. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention.
    Gerner EW; Meyskens FL; Goldschmid S; Lance P; Pelot D
    Amino Acids; 2007 Aug; 33(2):189-95. PubMed ID: 17396214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemoprevention of colorectal cancer].
    Benamouzig R; Chaussade S
    Presse Med; 2002 Jan; 31(3):124-7. PubMed ID: 11859737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
    Samadder NJ; Neklason DW; Boucher KM; Byrne KR; Kanth P; Samowitz W; Jones D; Tavtigian SV; Done MW; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Davis R; Topham MK; Lynch P; Strait E; McKinnon W; Burt RW; Kuwada SK
    JAMA; 2016 Mar 22-29; 315(12):1266-75. PubMed ID: 27002448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant DFMO and sulindac chemoprevention of colorectal adenomas: a major clinical advance.
    Sporn MB; Hong WK
    Nat Clin Pract Oncol; 2008 Nov; 5(11):628-9. PubMed ID: 18725921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenomas.
    DuBois RN
    Gastroenterology; 1995 Apr; 108(4):1310-4. PubMed ID: 7698600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in risk factor-colorectal adenoma associations according to non-steroidal anti-inflammatory drug use.
    Mujtaba S; Bostick RM
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1318-1326. PubMed ID: 30161027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
    Lawson KR; Ignatenko NA; Piazza GA; Cui H; Gerner EW
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1155-62. PubMed ID: 11097222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity.
    Kreul SM; Havighurst T; Kim K; Mendonça EA; Wood GS; Snow S; Borich A; Verma A; Bailey HH
    Cancer Prev Res (Phila); 2012 Dec; 5(12):1368-74. PubMed ID: 23060038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
    Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity.
    Curiel-Lewandrowski C; Swetter SM; Einspahr JG; Hsu CH; Nagle R; Sagerman P; Tangrea J; Parnes H; Alberts DS; Chow HH
    Cancer; 2012 Dec; 118(23):5848-56. PubMed ID: 22605570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
    Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
    J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.